Ondansetron Tablet, Orally Disintegrating
Product Images NDC 85766-038

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 85766-038). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sportpharm Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Label)

Label (Label)
Packaging labels for Ondansetron OD Tablets, USP 8 mg, an orally disintegrating tablet by Sportpharm LLC. Labels display multiple package sizes including quantities of 4, 6, 10, 20, and 30 tablets. Each label includes the NDC code corresponding to the package size, distributor information, drug status, and storage instructions.*
FDA Label Image

Chemical Structure (Ondansetronod Str)

Chemical Structure (Ondansetronod Str)
Chemical structure diagram of Ondansetron, showing the arrangement of its molecular components including rings and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.